| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Department of Molecular Cellular and Developmental Biology and the Neuroscience Research Institute, University of California, Santa Barbara, California, 93106
The epothilones are a group of novel microtubule-targeted, antimitotic compounds that have a paclitaxel-like, assembly enhancing effect on tubulin in vitro as well as in cultured cells. We hypothesize that epothilones induce mitotic arrest by suppressing microtubule dynamics. To test this hypothesis, we used MCF7 cells stably transfected with GFP-
-tubulin to analyze microtubule dynamics at three concentrations of epothilone B, one that induced no mitotic arrest (0.2 nM, 20 h), one that induced one-third maximal mitotic arrest (IC33, 2 nM, 20 h), and one that induced half-maximal mitotic arrest (IC50, 3.5 nM, 20 h). We found that epothilone B suppressed microtubule dynamics in a concentration-dependent manner coincident with mitotic block. At 0.2 nM epothilone B, dynamics were not significantly altered. At 2 nM epothilone B (IC33), the mean growth and shortening rates were decreased by 38 and 27%, respectively. Dynamicity was decreased by 47%. At the IC50, 80% of the cells had nearly complete stabilization of microtubule dynamics, and no anaphase or telophase figures were observed. Comparison of the effects of epothilone B on microtubule dynamics with those of paclitaxel indicated that both drugs alter the same microtubule dynamic parameters to a similar extent. At the IC50 for mitotic arrest, dynamicity was reduced by 54% by paclitaxel compared with 62% for epothilone B. In 65% of the cells treated with paclitaxel, the microtubules were completely stabilized. Thus, the effects of epothilone B on microtubule dynamics are remarkably similar to those of paclitaxel, suggesting that both drugs induce mitotic block by a similar mechanism.
This article has been cited by other articles:
![]() |
E. A. Perez Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance Mol. Cancer Ther., August 1, 2009; 8(8): 2086 - 2095. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Bekier, R. Fischbach, J. Lee, and W. R. Taylor Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit Mol. Cancer Ther., June 1, 2009; 8(6): 1646 - 1654. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhou, C. C. Vos, A. Gjyrezi, M. Yoshida, F. R. Khuri, F. Tamanoi, and P. Giannakakou The Protein Farnesyltransferase Regulates HDAC6 Activity in a Microtubule-dependent Manner J. Biol. Chem., April 10, 2009; 284(15): 9648 - 9655. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. T. Bach, S. Creed, J. Zhong, M. Mahmassani, G. Schevzov, J. Stehn, L. N. Cowell, P. Naumanen, P. Lappalainen, P. W. Gunning, et al. Tropomyosin Isoform Expression Regulates the Transition of Adhesions To Determine Cell Speed and Direction Mol. Cell. Biol., March 15, 2009; 29(6): 1506 - 1514. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dumontet, M. A. Jordan, and F. F.Y. Lee Ixabepilone: targeting {beta}III-tubulin expression in taxane-resistant malignancies Mol. Cancer Ther., January 1, 2009; 8(1): 17 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Azarenko, T. Okouneva, K. W. Singletary, M. A. Jordan, and L. Wilson Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane Carcinogenesis, December 1, 2008; 29(12): 2360 - 2368. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mohan and D. Panda Kinetic Stabilization of Microtubule Dynamics by Estramustine Is Associated with Tubulin Acetylation, Spindle Abnormalities, and Mitotic Arrest Cancer Res., August 1, 2008; 68(15): 6181 - 6189. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okouneva, O. Azarenko, L. Wilson, B. A. Littlefield, and M. A. Jordan Inhibition of centromere dynamics by eribulin (E7389) during mitotic metaphase Mol. Cancer Ther., July 1, 2008; 7(7): 2003 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Lee and S. M. Swain The Epothilones: Translating from the Laboratory to the Clinic Clin. Cancer Res., March 15, 2008; 14(6): 1618 - 1624. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ray, T. Okouneva, T. Manna, H. P. Miller, S. Schmid, L. Arthaud, R. Luduena, M. A. Jordan, and L. Wilson Mechanism of Action of the Microtubule-Targeted Antimitotic Depsipeptide Tasidotin (Formerly ILX651) and Its Major Metabolite Tasidotin C-Carboxylate Cancer Res., April 15, 2007; 67(8): 3767 - 3776. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Failly, S. Korur, V. Egler, J.-L. Boulay, M. M. Lino, R. Imber, and A. Merlo Combination of sublethal concentrations of epidermal growth factor receptor inhibitor and microtubule stabilizer induces apoptosis of glioblastoma cells Mol. Cancer Ther., February 1, 2007; 6(2): 773 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kamath, T. Okouneva, G. Larson, D. Panda, L. Wilson, and M. A. Jordan 2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules. Mol. Cancer Ther., September 1, 2006; 5(9): 2225 - 2233. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Jordan, K. Kamath, T. Manna, T. Okouneva, H. P. Miller, C. Davis, B. A. Littlefield, and L. Wilson The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth Mol. Cancer Ther., July 1, 2005; 4(7): 1086 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Marcus, J. Zhou, A. O'Brate, E. Hamel, J. Wong, M. Nivens, A. El-Naggar, T.-P. Yao, F. R. Khuri, and P. Giannakakou The Synergistic Combination of the Farnesyl Transferase Inhibitor Lonafarnib and Paclitaxel Enhances Tubulin Acetylation and Requires a Functional Tubulin Deacetylase Cancer Res., May 1, 2005; 65(9): 3883 - 3893. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kamath, L. Wilson, F. Cabral, and M. A. Jordan {beta}III-Tubulin Induces Paclitaxel Resistance in Association with Reduced Effects on Microtubule Dynamic Instability J. Biol. Chem., April 1, 2005; 280(13): 12902 - 12907. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pasquier, S. Honore, B. Pourroy, M. A. Jordan, M. Lehmann, C. Briand, and D. Braguer Antiangiogenic Concentrations of Paclitaxel Induce an Increase in Microtubule Dynamics in Endothelial Cells but Not in Cancer Cells Cancer Res., March 15, 2005; 65(6): 2433 - 2440. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lin, L. Catley, R. LeBlanc, C. Mitsiades, R. Burger, Y.-T. Tai, K. Podar, M. Wartmann, D. Chauhan, J. D. Griffin, et al. Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivo Blood, January 1, 2005; 105(1): 350 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Honore, K. Kamath, D. Braguer, S. B. Horwitz, L. Wilson, C. Briand, and M. A. Jordan Synergistic Suppression of Microtubule Dynamics by Discodermolide and Paclitaxel in Non-Small Cell Lung Carcinoma Cells Cancer Res., July 15, 2004; 64(14): 4957 - 4964. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goodin, M. P. Kane, and E. H. Rubin Epothilones: Mechanism of Action and Biologic Activity J. Clin. Oncol., May 15, 2004; 22(10): 2015 - 2025. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Honore, K. Kamath, D. Braguer, L. Wilson, C. Briand, and M. A. Jordan Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation Mol. Cancer Ther., December 1, 2003; 2(12): 1303 - 1311. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |